Conversation with The Cancer LetterCOVID-19 & CancerFree Northwell Health reopens cancer services after COVID-19 delugeNew York health system explores NCI designation in affiliation with Cold Spring Harbor Laboratory July 02, 2020Vol.46 No.27By Paul Goldberg
Drugs & TargetsFree FDA approves Keytruda for cutaneous squamous cell carcinoma June 26, 2020Vol.46 No.26
Drugs & TargetsFree Selinexor receives FDA approval for relapsed/refractory diffuse large B-cell lymphoma June 26, 2020Vol.46 No.26
Drugs & TargetsFree Keytruda approved in China for second-line treatment of locally advanced or metastatic ESCC indication June 26, 2020Vol.46 No.26
Clinical RoundupFree FDA pilot program to communicate patient reported outcomes from cancer clinical trials June 26, 2020Vol.46 No.26
Clinical RoundupFree Black cancer patients better represented in publicly-funded clinical trials June 26, 2020Vol.46 No.26
Clinical RoundupFree AI dual-stain approach improved accuracy, efficiency of cervical cancer screening in NCI study June 26, 2020Vol.46 No.26
Clinical RoundupFree IPATential150 study meets rPFS primary endpoint in mCRPC June 26, 2020Vol.46 No.26
Clinical RoundupFree City of Hope, TGen study shows T cells can predict how patients respond to immunotherapy June 26, 2020Vol.46 No.26
